Management of cardiovascular risk in clozapine patients: how can we optimise it?

被引：0
|
作者：
Hawes, A. [1 ]
Tran, T. [1 ]
Albuloushi, A. [1 ]
Parmar, S. [2 ]
Ally, B. [2 ]
Santos, J. M. Serrano [1 ]
机构：
[1] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia
[2] Queensland Hlth, Metro South & West Moreton, Brisbane, Qld, Australia
来源：
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY | 2016年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：E40 / E40
页数：1
相关论文
共 50 条
  • [31] Cardiovascular Risk Management in Seropositive Rheumatoid Arthritis: What Can We Do Better?
    McElwee, Matthew
    Boersma, Peter
    Hashmi, Hiba
    Shmagel, Anna K.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] HOW CAN WE REASSURE PATIENTS
    KNOWLES, LN
    AMERICAN JOURNAL OF NURSING, 1959, 59 (JUN) : 834 - 835
  • [33] The cardiovascular risk management for people living with HIV in Europe: how well are we doing?
    Shahmanesh, Maryam
    Schultze, Anna
    Burns, Fiona
    Kirk, Ole
    Lundgren, Jens
    Mussini, Cristina
    Pedersen, Court
    De Wit, Stephane
    Kutsyna, Galyna
    Mocroft, Amanda
    AIDS, 2016, 30 (16) : 2505 - 2518
  • [34] LASER LITHOTRIPTER SETTINGS ACCORDING TO ENDOSCOPIC VIEW: HOW CAN WE OPTIMISE THE OUTCOME? A SIMPLE WAY TO OPTIMISE THE TREATMENT STRATEGY
    Frego, Nicola
    Domanico, Luigi
    Maffei, Davide
    Paciotti, Marco
    Diana, Pietro
    Regis, Federica
    Bevilacqua, Giulio
    Fasulo, Vittorio
    Peschechera, Roberto
    Lazzeri, Massimo
    Hurle, Rodolfo
    Lughezzani, Giovanni
    Casale, Paolo
    Buffi, Nicolo Maria
    Guazzoni, Giorgio Ferruccio
    Saita, Alberto Rosario
    JOURNAL OF UROLOGY, 2020, 203 : E210 - E211
  • [35] COMMUNICATION IN CARDIOVASCULAR DISEASE PREVENTION: HOW CAN WE MAKE THE CONCEPT OF RISK MORE MEANINGFUL?
    Bonner, C.
    McKinn, S.
    Lau, A.
    Jansen, J.
    Irwig, L.
    Glasziou, P.
    Doust, J.
    McCaffery, K.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 : S225 - S225
  • [36] How can we best predict cardiovascular disease risk in type 1 diabetes? A comparison of risk equations
    Saunders, R.
    Boye, K.
    Bae, J.
    Norrbacka, K.
    Timlin, L.
    Pollock, R.
    Valentine, W.
    DIABETOLOGIA, 2014, 57 : S100 - S100
  • [37] HOW DO WE OPTIMISE PRODUCTION ON THIS SITE?
    Taylor, Clive
    Process Engineering (London), 1987, 68 (09):
  • [38] Congenital hyperinsulinism in Polish patients - how can we optimize clinical management?
    Buraczewska, Marta
    Szymanska, Ewa
    Brandt, Agnieszka
    Jarosz-Chobot, Przemyslawa
    Sykut-Cegielska, Jolanta
    Barg, Ewa
    Borowiec, Maciej
    Mlynarski, Wojciech
    Mysliwiec, Malgorzata
    ENDOKRYNOLOGIA POLSKA, 2015, 66 (04) : 322 - 328
  • [39] Evidence-Based Risk Management: How Can We Succeed?: Deliberations from a Risk Management Advisory Council
    Eleanor M. Perfetto
    Russell Ellison
    Susan Ackermann
    Marjorie Sherr
    Ana Maria Zaugg
    Drug information journal : DIJ / Drug Information Association, 2003, 37 : 127 - 134
  • [40] Evidence-based risk management: How can we succeed?: Deliberations from a risk management advisory council
    Perfetto, EM
    Ellison, R
    Ackermann, S
    Sherr, M
    Zaugg, AM
    DRUG INFORMATION JOURNAL, 2003, 37 (01): : 127 - 134
12345